Search database
Filter
4880
Text search: medicines
Featured
Language
Document type
2576
789
674
254
199
138
88
68
28
27
22
11
5
Countries
248
191
151
114
110
109
97
96
92
91
87
83
76
75
74
73
72
72
71
65
59
56
50
46
42
41
39
37
36
31
30
29
27
27
26
25
24
23
23
23
23
23
23
22
21
18
16
16
16
16
15
13
13
12
12
11
10
10
9
9
9
9
9
9
8
8
7
7
7
6
6
6
6
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
734
279
210
158
135
103
92
88
63
34
34
32
31
29
27
26
25
24
23
20
20
20
19
19
19
19
19
19
18
18
17
17
16
16
16
16
15
15
14
14
14
13
13
13
13
12
12
12
11
11
11
11
11
11
11
11
10
10
10
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1995
433
291
203
98
91
56
2
2
2
Toolboxes
379
377
295
289
280
252
154
129
128
111
107
96
96
93
91
78
51
40
20
16
12
11
7
2
1
 Download
  View PDF
 Add to my MEDBOX

Zambia: APPLICATION FOR MARKETING AUTHORISATION OF CONDOMS

Zambia Medicines Regulatory Authority (ZAMRA) (2016) C2
Guidance for the preparation and submission of dossiers
 Download
  View PDF
 Add to my MEDBOX

Zambia: GUIDELINES ON REGULATING THE CONDUCT OF CLINICAL TRIAL IN HUMAN PARTICIPANTS

Zambia Medicines Regulatory Authority (ZAMRA) (2016) C2
First Edition
 Download
  View PDF
 Add to my MEDBOX

Zambia: GENERAL GUIDELINES FOR SUBMITTING APPLICATIONS FOR REGISTRATION OF A MEDICINE

Zambia Medicines Regulatory Authority (ZAMRA) (2016) C2
First Edition
 Download
  View PDF
 Add to my MEDBOX

GUIDELINES FOR DETECTING AND REPORTING ADVERSE DRUG OR VACCINE REACTIONS AND EVENTS IN ZAMBIA

Zambia Medicines Regulatory Authority (ZAMRA) (2006) C2
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
 Add to my MEDBOX

Tripartite meeting held between the PMDA, EMA, and FDA in Kyoto, Japan to discuss convergence on approaches for the evaluation of antibacterial drugs

European Medicines Agency (2017) C2
Meeting summary
 External Link
 Add to my MEDBOX

COVID-19 Vaccine Moderna

European Medicines Agency EMA (2021) CC
 External Link
 Add to my MEDBOX

Treatments and vaccines for COVID-19

European Medicines Agency EMA (2021) CC
The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to enable promising medicines to reach patients as soon as possible. It is also interacting with medicine ... more
 External Link
 Add to my MEDBOX

COVID-19 Vaccine AstraZeneca(COVID-19 Vaccine (ChAdOx1-S [recombinant]))

European Medicines Agency EMA (2021) CC
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages 18 Febr. 2021
 External Link
 Add to my MEDBOX

COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update

European Medicines Agency EMA (2021) CC
11 March 2021
 External Link
 Add to my MEDBOX

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

European Medicines Agency EMA (2021) CC
7 April 2021
 Download
  View PDF
 Add to my MEDBOX

Standards for Prosthetics and Orthotics Service Provision. 2015-2017 work plan

Department of Essential Medicines and Health Products (EMP) and NVI World Health Organisation (WHO); USAID; ISPO (2015) C_WHO
 External Link
 Add to my MEDBOX

Global Health Hochschulranking

Universities Allied for Essential Medicines; Bundesvertretung der Medizinstudierenden in Deutschland (2019) C1
Ziel des Projektes ist es, den in Deutschland bisher unterrepräsentierten Bereich Global Health sichtbarer zu machen und gleichzeitig einen Anreiz für Fakultäten zu schaffen, sich hier vermehrt zu engagieren. Des Weiteren soll das Ranking interessierten und kritischen Studierenden eine Möglichke ... more
 Add to my MEDBOX

Guideline on the assessment of the risk to public health from antimicrobial resistance due to the use of an antimicrobial veterinary medicinal product in food producing animals

EMA European Medicines Agency (2018) C2
This guideline provides advice in regards to applications for Marketing Authorisations for antimicrobial veterinary medicinal products (VMPs) on the data required and the methodology to be used for performing an assessment of the risk to public health from antimicrobial resistance (AMR) due to use o ... more
 External Link
 Add to my MEDBOX

Buruli Ulcer: a Review of the Current Knowledge

Yotsu,R.R.; K. Suzuki, R. E. Simmonds et al. Current Tropical Medicines Report (2018) CC
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglected tropical diseases (skin NTDs). This article aim ... more
 Add to my MEDBOX

ECDC/EFSA/EMA second joint report on the integratedanalysis of the consumption of antimicrobial agents andoccurrence of antimicrobial resistance in bacteria fromhumans and food-producing animals

European Centre for Disease Prevention and Control (ECDC), European Food Safety Authority (EFSA) andEuropean Medicines Agency (EMA) (2017) C_CDC
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp ... more
 Download
  View PDF
 Add to my MEDBOX

Regional Strategy on Regulation of Medical Products in the African Region, 2016–2025

World Health Organization, Regional Office for Africa (2016) C_WHO
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines ... more
 Download
  View PDF
 Add to my MEDBOX

The Intersessional Post-exposure prophylaxis (PEP) 2021 - changes effective January 2021

World Health Organization WHO, ICRC, MSF, et al. (2021) C_WHO
Medicines and medical devices for 10 000 people for approximately three months
 External Link
 Add to my MEDBOX

Medical Information Service MIS Zimbabwe

Medical Information Service MIS (2022) CC
Finding out where certain medicines are provided and comparing prices of those medicines is unnecessarily hard in Zimbabwe. Something has to be done. That’s why The Medical Information Service -Th ... more
 Download
  View PDF
 Add to my MEDBOX

Receiving procedure Flowchart

Ecumenical Pharmaceutical Network (EPN) (2011) C2
Flow chart for receiving medicines procedure. Last revised 2015. Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Receiving%20procedure_Flowchart.doc
 Download
  View PDF
 Add to my MEDBOX

Background Paper 6.11 Alzheimer Disease and other Dementias

B. Duthey, Ph.D; S. Tanna (2004) C2
20 February 2013 Update on 2004 Background Paper (Written by Saloni Tanna) Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
 Add to my MEDBOX

Liste Nationale des Médicaments essentiels et dispositifs médicaux de la RCA 2017

Organisation Mondiale de la Santé OMS (2017) C_WHO
Essential Medicines and Health Products Information Portal
 Download
  View PDF
 Add to my MEDBOX

Specifications and quantities for efficient procurement of essential equipment and laboratory commodities for HIV

Francis Aboagye-Nyame, Heather Alexander, Zelalem Gizachew Belachew et al. World Health Organization (2015) C_WHO
Second Edition AIDS Medicines and diagnostics services July 2015
 Download
  View PDF
 Add to my MEDBOX

Solomon Islands Essential Medical Supplies List 2017

Sandy Greenwood, Timmy Manea, Willie Horoto et al. National Pharmacy Services Division, Ministry of Health & Medical Services (2017) CC
Solomon Islands pharmacy staff have developed an essential medicines supplies list. It was a collaborative effort involving a lot of staff taking the pictures and putting it all together. The list was launched as an initiative to improve the availab ... more
 Download
  View PDF
 Add to my MEDBOX

Medicine Prices in Nigeria

Federal Ministry of Health Nigeria , World Health Organisation (WHO), DFID, et al. (2006) C_WHO
Prices people pay for medicines.
 Add to my MEDBOX

Malawi Standard Treatment Guidelines (MSTG) 5th Edition
recommended

Ministry of Health, Malawi (2015) C1
Incorporating Malawi Essential Medicines List (MEML)
 Download
  View PDF
 Add to my MEDBOX

The Wise List 2015

Stockholm Drug and Therapeutics Committee (2015) C_WHO
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
 Download
  View PDF
 Add to my MEDBOX

Bhutan: National Essential Medicine List

World Health Organization WHO (2016) C_WHO
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier met ... more
 Download
  View PDF
 Add to my MEDBOX

Medicine's registration procedure in Madagascar

Ministry of Health, Madagascar (2016) C1
Procedures Manual - Medicines registration in Madagascar - 2016 version
 Download
  View PDF
 Add to my MEDBOX

HIV diagnostic in low- and middle-income countries: Forecasts of global demand for 2014–2018

E. Korenromp; M. Wareham; V. Habiyambere; et al. World Health Organization (2015) C_WHO
Technical Report AIDS Medicines and diagnostics service July 2015
 External Link
 Add to my MEDBOX

Understand Antibiotics - Website

ReAct (2019) C2
Antibiotics are important medicines for the treatment of bacterial infections in humans and animals. Since their introduction in the 1940’s antibiotics have saved countless lives and has made many medical techniques possible or safer.
 Download
  View PDF
 Add to my MEDBOX

ແຜນຍຸດທະສາດ ວ່າດ້ວຍການຕ້ານຕໍ່ເຊື້ອຈຸລະຊີບທີ່ຕ້ານຕ່ໍຢາຕ້ານເຊື້ອ ຂອງ ສປປ ລາວ, 2019 - 2023

World Health Organization WHO (2019) C_WHO
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລ ... more
 Download
  View PDF
 Add to my MEDBOX

Strengthening the Health Systems Response to COVID-19 - Technical guidance #3

World Health Organization (Europe) (2020) C_WHO
Supply of essential medicines and health technologies (6 April 2020) This paper is one of a set of technical guidance papers developed by the WHO Regional Office for Europe to provide practical information and resources for decision-makers on mea ... more
 Add to my MEDBOX

Lista de medicamentos esenciales para el manejo de pacientes que ingresan a unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID 19. Tercera versión, 1 de febrero del 2022
recommended

Organización Mundial de la Salud OMS OPS (2022) C_WHO
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
 Add to my MEDBOX

Оцінка доступності основних лікарських засобів для амбулаторного лікування в Україні

World Health Organization WHO, Regional Office of Europe (2021) C_WHO
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Me ... more
 Add to my MEDBOX

Antimicrobial Resistance Surveillance Guidance for the African Region

Africa Center for Disease Control and Prevention (2024) CC
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and ... more
 Download
  View PDF
 Add to my MEDBOX

Guide to Good Prescribing (Arabic version)

World Health Organization (1998) C_WHO
A practical manual to good prescription of medicines in Arabic language.
 Download
  View PDF
 Add to my MEDBOX

Guide to Good Prescribing (Romanian version) / Ghid pentru buna prescriere a medicamentelor

World Health Organization (WHO) (2000) C_WHO
A practical manual to good prescription of medicines in Romanian language. - Summary: Aceasta carte se adreseaza in primul rând studentilor la medicina. Ea ofera un ghid în procesul de prescriere rationala a medicamentelor, împreuna cu numeroase ... more
 Download
  View PDF
 Add to my MEDBOX

Guide to Good Prescribing (Russian version)

World Health Organization (WHO) (1997) C_WHO
A practical manual to good prescription of medicines in Russian language
 Download
  View PDF
 Add to my MEDBOX

Guide to Good Prescribing (Bengali version)

World Health Organization (WHO) (1998) C_WHO
A practical manual to good prescription of medicines in Bengali language.
 Download
  View PDF
 Add to my MEDBOX

Workplan Form

Ecumenical Pharmaceutical Network (EPN) (2011) C2
Annual procurement workplan for ordering medicines. Last revised 2015. Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Workplan_Form.doc
 Download
  View PDF
 Add to my MEDBOX

Lesotho: DRUGS OF ABUSE ACT OF 2008

Parliament of Lesotho (2008) C2
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals ... more
 Download
  View PDF
 Add to my MEDBOX

ОЦІНКА ПРОГРАМИ «ДОСТУПНІ ЛІКИ» В УКРАЇНІ

World Health Organization WHO, Regional Office of Europe (2019) C_WHO
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatme ... more
 External Link
 Add to my MEDBOX

Emergency health kits
recommended

World Health Organization WHO (2022) C_WHO
WHO has developed standardized health kits of medicines and medical supplies to meet different health needs in humanitarian emergencies and disasters. These kits are developed to provide reliable and affordable ... more
 Download
  View PDF
 Add to my MEDBOX

Malaria chemoprevention efficacy study protocol

World Health Organization WHO (2022) C_WHO
Chemoprevention is the use of medicines, either alone or in combination, to prevent malaria infection and its consequences. This publication provides standardized approaches for monitoring and evaluating the efficacy of ... more
 Download
  View PDF
 Add to my MEDBOX

The Interagency Emergency Health Kit 2017
recommended

World Health Organization WHO; UNICEF; ICRC; et al. (2019) C_WHO
Interagency Guidelines; Medicines and medical devices for 10 000 people for approximately three month.
 External Link
 Add to my MEDBOX

WHO Model Formulary for Children
recommended

World Health Organization WHO (2010) C_WHO
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009. In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Chil ... more
 Download
  View PDF
 Add to my MEDBOX

A model quality assurance system for procurement agencies

World Health Organization World Health Organization, United Nations Children's Fund, United Nations Development Programme, United Nations Populations Fund, World Bank (2007) C_WHO
This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products ... more
 Add to my MEDBOX

WHO Guideline on Country Pharmaceutical Pricing Policies

World Health Organization WHO World Health Organization (2020) C_WHO
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov ... more
 External Link
 Add to my MEDBOX

Counterfeit drugs and medical devices in developing countries

Beverly D Glass (2014) CC
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while f ... more
 Add to my MEDBOX

Pharmacological treatment of mental disorders in primary health care

World Health Organization WHO (2009) CC
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; an ... more
 Download
  View PDF
 Add to my MEDBOX

Falling short

International Union Against Tuberculosis and Lung Disease; Treatment Action Group; msh; ec al. (2017)
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis. Accessed in November 2017.
 External Link
 Add to my MEDBOX

Experimental Ebola drugs face tough test in war zone

Maxman, A. (2018) C2
Researchers are devising a clinical-trial protocol to test three medicines in Africa's latest outbreak Nature doi: 10.1038/d41586-018-06132-7
 Download
  View PDF
 Add to my MEDBOX

Healthy animals, Happy farmers!

Food and Agriculture Organization (FAO) (2016) C2
When an infection strikes, and medicines like antibiotics (and other antimicrobials) do not work, you can lose your entire stock of animals to disease. This also puts the health of you and your family at risk when the infection can spread between an ... more
 Download
  View PDF
 Add to my MEDBOX

The Importance of Pharmacovigilance

World Health Organization WHO (2020) C_WHO
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging partic ... more
 Download
  View PDF
 Add to my MEDBOX

Kenya Pharmaceutical Sector Development Strategy

United Nations Industrial Develoopment Organization (2012) C1
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
 Add to my MEDBOX

Diagnostics, medical devices & other health products catalog (GDF)

Stop TB Partnership World Health Organization WHO (2022) C_WHO
GDF is the largest global provider of quality-assured tuberculosis (TB) medicines, diagnostics, and laboratory supplies to the public sector. Since 2001, GDF has facilitated access to high-quality TB care in over 130 countries, providing treatmen ... more
 External Link
 Add to my MEDBOX

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC
In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide ... more
 External Link
 Add to my MEDBOX

Where There Are No Pharmacists

Sarah Andersson; Beverley Snell Third World Network; Health Action International Asia Pacific (2019) C2
2nd edition. A Guide to Managing Medicines for All Health Workers. Available for purchase via following link https://www.twn.my/title2/books/HAI.htm Where there are no trained pharmacists serving communities, other categories of health workers ar ... more
 Download
  View PDF
 Add to my MEDBOX

Rwanda: MOH GUIDELINES ON SUBMISSION OF DOCUMENTATION FOR REGISTRATION OF HUMAN PHARMACEUTICAL PRODUCTS

Ministry of Health, Rwanda (2014) C2
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and ... more
 Download
  View PDF
 Add to my MEDBOX

Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)
recommended

World Health Organization WHO (2018) C_WHO
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be incr ... more
 Add to my MEDBOX

Antimicrobial stewardship: changing risk-related behaviours in the general population

National Institut for Health and Care Excellence NICE (2017) C2
This guideline covers making people aware of how to correctly use antimicrobial medicines (including antibiotics) and the dangers associated with their overuse and misuse. It also includesmeasures to prevent and control infection that can stop peopl ... more
 Add to my MEDBOX

Recommendations for Implementing Antimicrobial Stewardship Programs in Latin America and the Caribbean: Manual for Public Health Decision-Makers

Pan American Health Organization PAHO (2018) C2
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In ad ... more
 External Link
 Add to my MEDBOX

Pathways of antibiotic use in Bangladesh: qualitative protocol for the PAUSE study

Rousham E. K., M. Aminul Islam, P. Nahar et al. (2018) C2
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibioti ... more
 Add to my MEDBOX

WHO good manufacturing practices for pharmaceutical products: main principles

World Health Organization WHO (2014) C_WHO
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status, ... more
 Download
  View PDF
 Add to my MEDBOX

Regulatory guidance for assessment and management of applications for marketing authorization of oxytocin

World Health Organization WHO (2021) C_WHO
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically ... more
 Download
  View PDF
 Add to my MEDBOX

WHO technical consultation on preferred product characteristics for drugs used in malaria chemoprevention

World Health Organization WHO (2022) C_WHO
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation ... more
 Add to my MEDBOX

It's my COPD Action Plan - COPD Foundation

COPD Foundation (2024) CC2
Please complete the section below. Bring all your medicines and inhalers along with a complete list to doctor’s office visits. Think about your ability to perform these activities on a typical “green” day. Place one check mark in each column. ... more
 Add to my MEDBOX

How to use your Inhaler device

Allergy Foundation South Africa (2024) CC2
Using an inhaler is the most common and effective way of taking asthma medicines. If you’re NOT using your inhaler correctly, you might not be getting the full dose of medicine your doctor or asthma nurse prescribed because the medicine can’t re ... more
 Add to my MEDBOX

Antimicrobial resistance and access to antibiotics

World Health Organization WHO EMHJ – Vol. 30 No. 12 – 2024 (2024) C_WHO
It is estimated that around 2 billion people worldwide do not have access to essential medicines. Access to medicines in the Eastern Mediterranean Region varies among countries, depending on their i ... more
 Download
  View PDF
 Add to my MEDBOX

Harmonized monitoring and evaluation indicators for procurement and supply management systems

WHO (2011) C_WHO
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
 Add to my MEDBOX

The fight against fake drugs by NAFDAC in Nigeria

The fight against fake drugs by NAFDAC in Nigeria Olike Chinwendu KIT (Royal Tropical Institute) Development Policy & Practice Vrije Universiteit Amsterdam (2008) CC
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
 Download
  View PDF
 Add to my MEDBOX

Patents and licences on antiretrovirals: A snapshot

UNITAID; WHO (2014)
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV ... more
 Download
  View PDF
 Add to my MEDBOX

Medicine Information for Primary Care in Zimbabwe

Ministry of Health and Social Welfare, Zimbabwe (2012) C1
The objective of this book is to provide health workers with easily accessible information on important aspects of the medicines commonly used at primary care level in Zimbabwe. Medicines are a cruc ... more
 Download
  View PDF
 Add to my MEDBOX

Using indicators to measure country pharmaceutical situations

WHO World Health Organization (WHO) (2006) C_WHO
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa ... more
 External Link
 Add to my MEDBOX

Antimicrobial Resistance (Part 1 and 2). E-Learning Course
recommended

Clark, A.; and M.P.Joshi Global Health Elearning Center (2016) CC
Antimicrobial resistance (AMR) occurs when disease-causing pathogens are able to withstand the killing or suppressing power of antimicrobial medicines. This phenomenon increases the global burden of infectious diseases and strains health systems.Thi ... more
 Download
  View PDF
 Add to my MEDBOX

Botswana: Guidelines for stability testing of pharmaceutical products

Ministry of Health, Gabarone, Botswana (2009) C2
This guideline is intended to provide requirements to applicants wishing to submit applications for registration of medicines in Botswana.
 External Link
 Add to my MEDBOX

Cholera kits 2020
recommended

World Health Organization (WHO) (2020) C_WHO
For several years, agencies supporting preparedness and response to cholera outbreaks have supplied medicines and medical devices through the Interagency Diarrhoeal Disease Kits (IDDK). In an effort to better align the presentation and content of ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Pharmacovigilance and Medicine Information in Rwanda (2016)

Ministry of Health, Rwanda (2016) C2
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
 Download
  View PDF
 Add to my MEDBOX

Updating national essential medicine lists: a step-by-step advocacy guide

MSH Management Sciences for Health (MSH) (2016) C1
This guide provides national stakeholders and advocates with information and guidance to update the national essential medicines list to include a new commodity, a new indication, or a new formulation based on the available evidence and based on cou ... more
 Download
  View PDF
 Add to my MEDBOX

The Public Health Dimension of the World Drug problem

World Health Organization WHO (2019) C_WHO
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
 Download
  View PDF
 Add to my MEDBOX

Getting it right: WHO guidance to diagnose correctly 90% of people living with HIV

A. Sands World Health Organization (2015) C_WHO
8th IAS Conference on HIV Pathogenesis 19-22 July 2015 Vancouver Anita Sands Prequalification Team – Diagnostics Essential Medicines and Health Product
 Add to my MEDBOX

FAO Action Plan on AMR in food and agriculture

Food and Agriculture Organization of the United Nations FAO (2016) C2
Antimicrobial resistance (AMR) is a threat to human and animal health and refers to the ability of microorganisms to defy the medicines prescribed. For instance when antibiotics are used improperly, such as an incorrect dose, insufficient duration o ... more
 External Link
 Add to my MEDBOX

Tutorial of local production of alcohol-based solution (WHO formulation)

WHO Collaborating Centre of Patient Safety Infection Control & Improving Practices; Hôpitaux Universitaires de Genève (HUG); Pharm-Ed WHO Collaborating Centre of Patient Safety Infection Control & Improving Practices; Hôpitaux Universitaires de Genève (HUG); Pharm-Ed (2016) C2
14.04.2016 Pharm -Ed -- The alcohol-based solution for hand hygiene is now part of the WHO essential medicines list .Local production of the alcohol-based handrub is an alternative to commercial products. Although adapted to contexts with limited ... more
 External Link
 Add to my MEDBOX

Factsheet for the general public - Antimicrobial resistance

European Centers for Disease Control and Prevention ECDC (2019) C2
Antibiotics, also known as antimicrobial drugs, are medicines that can kill or inhibit the growth of bacteria to cure infections in people, animals and sometimes plants. Antibiotics are medicines fo ... more
 Download
  View PDF
 Add to my MEDBOX

Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy
recommended

World Health Organization WHO (2022) C_WHO
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthi ... more
 External Link
 Add to my MEDBOX

WHO Science in 5 Episode #86 - Microbes are becoming resistant to antibiotics

World Health Organization WHO (2022) CC
Microbes like bacteria, fungus and viruses are becoming resistant to medicines like antibiotics. WHO has declared antimicrobial resistance as a global health and developmental threat. How can we stop antimicrobial resistance? Dr Hanan Balkhy explai ... more
 External Link
 Add to my MEDBOX

United against Rabies Collaboration

World Health Organization WHO (2019) C_WHO
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are children ... more
 External Link
 Add to my MEDBOX

Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030: United Against Rabies Collaboration: first annual progress report

World Health Organization WHO (2019) C_WHO
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are childre ... more
 Download
  View PDF
 Add to my MEDBOX

Health needs assessment of the adult population in Ukraine: survey report September 2022

World Health Organisation WHO (2023) C_WHO
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully co ... more
 External Link
 Add to my MEDBOX

Case study: Developing sustainable tools to improve community engagement and enhance Neglected Tropical Diseases programme equity

Countdown - Calling time on neglected tropical diseases (2023) C2
Accessed on 31.03.2023 COUNTDOWN Nigeria has applied a Participatory Action Research (PAR) approach to improve equity of Mass Administration of Medicines (MAM) and inform Neglected Tropical Disease (NTD) policy through an enhanced community enga ... more
 External Link
 Add to my MEDBOX

From animal use to a mainstay treatment against intestinal worms in humans

World Health Organization WHO (2023) C_WHO
Website last accessed on 14.04.2023 One of the ongoing challenges with neglected tropical diseases (NTDs) is that the discovery of medicines to treat them has been very slow. Current global programmes for NTDs largely depend on donated ... more
 External Link
 Add to my MEDBOX

Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries

Wirtz, V.J.; Kaplan, W.A.; Kwan, G.F. Circulation (2016) CC
Cardiovascular diseases (CVD) represent the highest burden of disease globally. Medicines are a critical intervention used to prevent and treat CVD. This review describes access to medication for CVD from a health system perspective and strategies t ... more
 Add to my MEDBOX

WHO Guidelines on Good Manufacturing Practices (GMP) for Herbal Medicine
recommended

World Health Organization WHO (2007) C_WHO
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
 Download
  View PDF
 Add to my MEDBOX

Safety Monitoring of medicinal products

Uppsala Monitoring Centre World Health Organization (2012) C_WHO
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effec ... more
 Download
  View PDF
 Add to my MEDBOX

Guide Material for Medical Store Management Training
recommended

Community Development Medicinal Unit (2012) C_WHO
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of ... more
 Download
  View PDF
 Add to my MEDBOX

Antimicrobial Resistance (AMR)

Deininger, K. The MEDBOX Team (2023) CC
Issue Brief 31: Antimicrobial resistance (AMR) can occur when viruses, bacteria, parasites and fungi change over time. There is no longer a response to medicines, and the infection treatment gets really difficult which increases the risk of a disesa ... more
 Add to my MEDBOX

Worldwide country situation analysis: response to antimicrobial resistance

World Health Organization (2015) C_WHO
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant ... more
 Download
  View PDF
 Add to my MEDBOX

WHO Pharmaceutical Situation Assessment – Level II – Health Facilities Services Ghana

Daniel Kojo Arhinful Ministry of Health, Ghana (2009) C1
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor ... more
 Download
  View PDF
 Add to my MEDBOX

Global Action Plan on Antimicrobial Resistance
recommended

World Health Organization WHO (2015) C_WHO
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and acces ... more
 Download
  View PDF
 Add to my MEDBOX

Keputusan Menteri Kesehatan Republik Indonesia Nomor 2500/MENKES/SK/XII /2011 tentang Daftar Obat Esensial Nasional 2011

Ministry of Health Republic of Indonesia (2011) C1
Decree of the Minister of Health of the Republic of Indonesia No. 2500 / MENKES / SK / XII / 2011 on National Essential Medicines List 2011